Mark Sun
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- RNA and protein synthesis mechanisms 5
- Protein Structure and Dynamics 4
- RNA Research and Splicing 4
- RNA modifications and cancer 3
- Bioinformatics and Genomic Networks 3
-
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Janine Senz (2 shared papers)Sohrab P. Shah (2 shared papers)Philip M. Kim (6 shared papers)Marco A. Marra (2 shared papers)Gavin Ha (2 shared papers)Martin Hirst (2 shared papers)David George Huntsman (2 shared papers)Malachi Griffith (1 shared paper)
- Journals
- PLoS Computational Biology (4 papers)Nature (2 papers)Bioinformatics (1 paper)Science Advances (1 paper)npj Genomic Medicine (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark Sun
20 papers receiving 3.2k citations
Mark Sun's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 943
- Reproductive Medicine 363
- Pathology and Forensic Medicine 557
- Oncology 696
- Molecular Biology 1.6k
Countries citing papers authored by Mark Sun
This map shows the geographic impact of Mark Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sun more than expected).
Fields of papers citing papers by Mark Sun
This network shows the impact of papers produced by Mark Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sun. The network helps show where Mark Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution Hit paper breakdown → | 2009 | 895 |
| 2 | Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary Hit paper breakdown → | 2009 | 640 |
| 3 | MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers Hit paper breakdown → | 2011 | 511 |
| 4 | 2011 | 436 | |
| 5 | 2009 | 268 | |
| 6 | 2010 | 172 | |
| 7 | 2017 | 81 | |
| 8 | 2013 | 60 | |
| 9 | 2021 | 54 | |
| 10 | 2012 | 45 | |
| 11 | 1992 | 36 | |
| 12 | 2016 | 34 | |
| 13 | 2012 | 27 | |
| 14 | 2018 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2017 | 13 | |
| 17 | 1999 | 3 | |
| 18 | 2023 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2014 | 1 |
About Mark Sun
Mark Sun is a scholar working on Molecular Biology, Immunology, Genetics, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 20 papers that have together received 3.3k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), Protein Structure and Dynamics (4 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers), Bioinformatics and Genomic Networks (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (943 citations), Reproductive Medicine (363 citations), Pathology and Forensic Medicine (557 citations), Oncology (696 citations) and Molecular Biology (1.6k citations). Mark Sun has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Janine Senz, Sohrab P. Shah, Philip M. Kim, Marco A. Marra, Gavin Ha, Martin Hirst, David George Huntsman, Malachi Griffith, Cenk Sahinalp and Marina Pacheco. Their work appears in journals such as PLoS Computational Biology, Nature, Bioinformatics, Science Advances and npj Genomic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.